The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time
- 19 June 2019
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 82 (1), 72-79
- https://doi.org/10.1016/j.jaad.2019.06.025
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (1P30-AR-069589-01)
- NIAMS
- National Institutes of Health (T32-AR-007465)
- NIAMS (K23-AR-068433)
- Pfizer
- Lilly
- Novartis
This publication has 15 references indexed in Scilit:
- Standardized laboratory monitoring with use of isotretinoin in acneJournal of the American Academy of Dermatology, 2016
- Guidelines of care for the management of acne vulgarisJournal of the American Academy of Dermatology, 2016
- Computer-assisted expert case definition in electronic health recordsInternational Journal of Medical Informatics, 2016
- Laboratory Monitoring During Isotretinoin Therapy for AcneJAMA Dermatology, 2016
- The use of oral antibiotics before isotretinoin therapy in patients with acneJournal of the American Academy of Dermatology, 2015
- Validating the diagnostic code for acne in a tertiary care dermatology centreEuropean Journal of Dermatology, 2015
- Effects of GOLD-Adherent Prescribing on COPD Symptom Burden, Exacerbations, and Health Care Utilization in a Real-World SettingChronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 2015
- A Population-Based Analysis of Laboratory Abnormalities During Isotretinoin Therapy for Acne VulgarisArchives of Dermatology, 2006
- Management of AcneJournal of the American Academy of Dermatology, 2003
- Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function testsBritish Journal of Dermatology, 1993